Ventyx Biosciences, Inc. (VTYX)
NASDAQ: VTYX · IEX Real-Time Price · USD
4.730
-0.250 (-5.02%)
At close: May 17, 2024, 4:00 PM
4.780
+0.050 (1.06%)
After-hours: May 17, 2024, 7:01 PM EDT
Ventyx Biosciences Market Cap
Ventyx Biosciences has a market cap or net worth of $334.17 million as of May 17, 2024. Its market cap has decreased by -84.81% in one year.
Market Cap
334.17M
Enterprise Value
42.10M
1-Year Change
-84.81%
Ranking
Category
Stock Price
$4.73
Market Cap Chart
Since the IPO on October 21, 2021, Ventyx Biosciences's market cap has decreased from $782.89M to $334.17M, a decrease of -57.32%. That is a compound annual growth rate of -28.17%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 333.50M | -5.01% |
May 16, 2024 | 351.10M | 18.86% |
May 15, 2024 | 295.40M | 0.48% |
May 14, 2024 | 294.00M | 1.20% |
May 13, 2024 | 290.50M | 0.76% |
May 10, 2024 | 288.30M | -8.71% |
May 9, 2024 | 315.80M | 20.03% |
May 8, 2024 | 263.10M | -3.59% |
May 7, 2024 | 272.90M | -2.22% |
May 6, 2024 | 279.10M | -2.89% |
May 3, 2024 | 287.40M | -1.20% |
May 2, 2024 | 290.90M | 4.90% |
May 1, 2024 | 277.30M | 25.14% |
Apr 30, 2024 | 221.60M | -2.46% |
Apr 29, 2024 | 227.20M | -2.45% |
Apr 26, 2024 | 232.90M | -3.20% |
Apr 25, 2024 | 240.60M | -4.22% |
Apr 24, 2024 | 251.20M | -2.52% |
Apr 23, 2024 | 257.70M | 1.14% |
Apr 22, 2024 | 254.80M | -3.81% |
Apr 19, 2024 | 264.90M | 2.79% |
Apr 18, 2024 | 257.70M | -0.69% |
Apr 17, 2024 | 259.50M | -7.98% |
Apr 16, 2024 | 282.00M | 1.92% |
Apr 15, 2024 | 276.70M | 1.50% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Nautilus Biotechnology | 359.51M |
Aura Biosciences | 356.71M |
Solid Biosciences | 354.38M |
Treace Medical Concepts | 354.07M |
Precigen | 353.14M |
Pulmonx | 349.54M |
Zynex | 348.89M |
Skye Bioscience | 347.06M |